JPWO2023234416A5 - - Google Patents

Info

Publication number
JPWO2023234416A5
JPWO2023234416A5 JP2024524962A JP2024524962A JPWO2023234416A5 JP WO2023234416 A5 JPWO2023234416 A5 JP WO2023234416A5 JP 2024524962 A JP2024524962 A JP 2024524962A JP 2024524962 A JP2024524962 A JP 2024524962A JP WO2023234416 A5 JPWO2023234416 A5 JP WO2023234416A5
Authority
JP
Japan
Prior art keywords
affinity
compound
amino acid
salt
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024524962A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023234416A1 (https=
JP7845464B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/020712 external-priority patent/WO2023234416A1/ja
Publication of JPWO2023234416A1 publication Critical patent/JPWO2023234416A1/ja
Publication of JPWO2023234416A5 publication Critical patent/JPWO2023234416A5/ja
Application granted granted Critical
Publication of JP7845464B2 publication Critical patent/JP7845464B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024524962A 2022-06-02 2023-06-02 親和性物質、化合物、抗体およびそれらの塩 Active JP7845464B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2022090443 2022-06-02
JP2022090443 2022-06-02
JP2022141780 2022-09-06
JP2022141780 2022-09-06
PCT/JP2023/020712 WO2023234416A1 (ja) 2022-06-02 2023-06-02 親和性物質、化合物、抗体およびそれらの塩

Publications (3)

Publication Number Publication Date
JPWO2023234416A1 JPWO2023234416A1 (https=) 2023-12-07
JPWO2023234416A5 true JPWO2023234416A5 (https=) 2025-07-29
JP7845464B2 JP7845464B2 (ja) 2026-04-14

Family

ID=89025083

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024524962A Active JP7845464B2 (ja) 2022-06-02 2023-06-02 親和性物質、化合物、抗体およびそれらの塩

Country Status (7)

Country Link
US (1) US20250101129A1 (https=)
EP (1) EP4534547A1 (https=)
JP (1) JP7845464B2 (https=)
KR (1) KR20250019100A (https=)
CN (1) CN119301142A (https=)
AU (1) AU2023279467A1 (https=)
WO (1) WO2023234416A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025121429A1 (ja) * 2023-12-06 2025-06-12 味の素株式会社 Fc-細胞複合体およびその製造方法
WO2026058917A1 (ja) * 2024-09-10 2026-03-19 味の素株式会社 抗体親和性物質を含む化合物、修飾抗体およびそれらの塩ならびに抗体誘導体または抗体-機能性物質コンジュゲートの製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4035855B2 (ja) 1996-06-05 2008-01-23 味の素株式会社 L−リジンの製造法
EP1240337B1 (en) 1999-12-24 2006-08-23 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
CN1250722C (zh) 2001-03-30 2006-04-12 味之素株式会社 分泌生产蛋白质的方法
JP4595506B2 (ja) 2004-11-25 2010-12-08 味の素株式会社 L−アミノ酸生産菌及びl−アミノ酸の製造方法
CA2614145A1 (en) 2005-07-05 2007-01-11 Ribomic Inc. Nucleic acid capable of binding to immunoglobulin g and use thereof
WO2008054030A1 (fr) 2006-11-02 2008-05-08 Kagoshima University Peptide liant l'igg
US9221882B2 (en) 2010-05-21 2015-12-29 Technische Universitat Munchen Biosynthetic proline/alanine random coil polypeptides and their uses
JP5994068B2 (ja) 2011-08-24 2016-09-21 国立大学法人 鹿児島大学 IgG結合性ペプチド及びそれによるIgGの検出および精製方法
EP2772546B1 (en) 2011-10-25 2019-05-15 Ajinomoto Co., Inc. Secretion production method for protein
WO2015095412A1 (en) 2013-12-19 2015-06-25 Zhong Wang Bispecific antibody with two single-domain antigen-binding fragments
DK3287523T3 (da) 2015-04-24 2022-07-25 Ajinomoto Kk Fremgangsmåde til sekretorisk fremstilling af protein
ES3058443T3 (es) 2015-05-20 2026-03-10 Univ Kagoshima Modificación específica de anticuerpo con péptido de unión a IgG
AU2018259856B2 (en) 2017-04-28 2025-05-01 Ajinomoto Co., Inc. Compound having substance that has affinity for soluble protein, cleavable moiety, and reactive group, or salt thereof
JPWO2019240288A1 (ja) 2018-06-14 2021-07-26 味の素株式会社 抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩
KR102921757B1 (ko) 2018-06-14 2026-02-03 아지노모토 가부시키가이샤 항체에 대한 친화성 물질, 절단성 부분 및 반응성기를 갖는 화합물 또는 이의 염
WO2020009165A1 (ja) 2018-07-03 2020-01-09 味の素株式会社 修飾抗体およびその製造方法
JPWO2020090979A1 (ja) 2018-10-31 2021-09-24 味の素株式会社 抗体に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩
TWI886164B (zh) * 2019-10-24 2025-06-11 國立大學法人鹿兒島大學 1價ccap生成物之製造方法
EP4071178A4 (en) 2019-12-06 2024-10-09 Ajinomoto Co., Inc. METHOD FOR PREPARING A PEPTIDE WITH PHYSIOLOGICAL ACTIVITY AND A PEPTIDE WITH A SHORT LINKER
JP7670072B2 (ja) 2021-01-18 2025-04-30 味の素株式会社 化合物またはその塩、およびそれらにより得られる抗体
CA3208296A1 (en) 2021-01-18 2022-07-21 Ajinomoto Co., Inc. Compound or salt thereof, and antibody obtained by using the same
KR20240032941A (ko) 2021-07-07 2024-03-12 아지노모토 가부시키가이샤 비천연 아미노산 함유 단백질의 분비 생산법

Similar Documents

Publication Publication Date Title
JPWO2023234416A5 (https=)
Timpl et al. Laminin–a glycoprotein from basement membranes.
JP2023052910A5 (https=)
CA2468583A1 (en) Self-assembling multimeric binding complexes derived from ab5 toxin family members
WO2021092075A1 (en) IL-2RβγC BINDING COMPOUNDS
SI1642972T1 (sl) Terapevtske uporabe BR X topnih receptorjev
EP4017866A1 (en) Methods of making incretin analogs
CA2318482A1 (en) Il-18 receptors
JP2019506140A5 (https=)
JP2011501951A5 (https=)
JP2017518748A5 (https=)
JP2000512633A (ja) チオエーテル結合を含む環状ポリペプチドおよびそれらの調製方法
JPWO2022191283A5 (https=)
DE896583T1 (de) Neue osp-c abgeleitete peptidefragmente
JP2024547218A5 (https=)
JP2016520529A5 (https=)
US5444150A (en) Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US8013115B1 (en) Use of stabilised synthetic compounds in immunoassay
JPH11505804A (ja) I型コラーゲンの架橋結合されたn−テロペプチドの合成ペプチド同族体
Wade et al. Use of thiazolidine-mediated ligation for site specific biotinylation of mouse EGF for biosensor immobilisation
JPWO2022154116A5 (https=)
JP2022521353A5 (https=)
US10005826B2 (en) Compounds that bind to the erythropoietin receptor
Drakopoulou et al. Engineering a CD4 mimetic inhibiting the binding of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein gp120 to human lymphocyte CD4 by the transfer of a CD4 functional site to a small natural scaffold
JP2007526919A5 (https=)